Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Related Citations for PubMed (Select 23708152)

1.

A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells.

Lee YS, Lee DG, Lee JY, Kim TR, Hong SS, Kwon SW, Kim YS.

Int J Oncol. 2013 Aug;43(2):591-9. doi: 10.3892/ijo.2013.1964. Epub 2013 May 27.

PMID:
23708152
2.

Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.

Lee JY, Jung KH, Morgan MJ, Kang YR, Lee HS, Koo GB, Hong SS, Kwon SW, Kim YS.

Mol Cancer Ther. 2013 Mar;12(3):274-85. doi: 10.1158/1535-7163.MCT-12-0054. Epub 2012 Oct 10.

3.

Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress.

Moon DO, Park SY, Choi YH, Ahn JS, Kim GY.

Biochem Pharmacol. 2011 Dec 1;82(11):1641-50. doi: 10.1016/j.bcp.2011.08.019. Epub 2011 Aug 31.

PMID:
21903093
4.
5.

5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.

Yang JF, Cao JG, Tian L, Liu F.

Cancer Chemother Pharmacol. 2012 Jan;69(1):195-206. doi: 10.1007/s00280-011-1686-9. Epub 2011 Jun 10.

PMID:
21660448
7.

Isoobtusilactone A sensitizes human hepatoma Hep G2 cells to TRAIL-induced apoptosis via ROS and CHOP-mediated up-regulation of DR5.

Chen CY, Yiin SJ, Hsu JL, Wang WC, Lin SC, Chern CL.

J Agric Food Chem. 2012 Apr 4;60(13):3533-9. doi: 10.1021/jf2051224. Epub 2012 Mar 21.

PMID:
22400995
8.

Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.

Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.

Mol Cancer Res. 2008 Dec;6(12):1852-60. doi: 10.1158/1541-7786.MCR-08-0012.

9.
10.

beta-Ionone enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells through Sp1-dependent upregulation of DR5 and downregulation of NF-kappaB activity.

Kim MO, Moon DO, Kang CH, Kwon TK, Choi YH, Kim GY.

Mol Cancer Ther. 2010 Apr;9(4):833-43. doi: 10.1158/1535-7163.MCT-09-0610. Epub 2010 Mar 30.

11.

Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.

Moon DO, Asami Y, Long H, Jang JH, Bae EY, Kim BY, Choi YH, Kang CH, Ahn JS, Kim GY.

Toxicol In Vitro. 2013 Feb;27(1):257-63. doi: 10.1016/j.tiv.2012.09.001. Epub 2012 Sep 12.

PMID:
22982206
12.

Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

Chen KF, Yeh PY, Hsu C, Hsu CH, Lu YS, Hsieh HP, Chen PJ, Cheng AL.

J Biol Chem. 2009 Apr 24;284(17):11121-33. doi: 10.1074/jbc.M806268200. Epub 2009 Mar 4.

13.

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.

Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96.

14.

Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors.

Sung B, Prasad S, Ravindran J, Yadav VR, Aggarwal BB.

Free Radic Biol Med. 2012 Nov 15;53(10):1977-87. doi: 10.1016/j.freeradbiomed.2012.08.012. Epub 2012 Aug 15.

15.

Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.

Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.

Biochem Pharmacol. 2012 Mar 15;83(6):769-77. doi: 10.1016/j.bcp.2011.12.035. Epub 2012 Jan 2.

PMID:
22230479
16.

Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.

Woo JS, Kim SM, Jeong CH, Ryu CH, Jeun SS.

Biochem Biophys Res Commun. 2013 Feb 8;431(2):354-9. doi: 10.1016/j.bbrc.2012.11.134. Epub 2012 Dec 19.

PMID:
23261452
17.

An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins.

Subramaniam A, Loo SY, Rajendran P, Manu KA, Perumal E, Li F, Shanmugam MK, Siveen KS, Park JI, Ahn KS, Hui KM, Kumar AP, Sethi G.

Apoptosis. 2013 Oct;18(10):1175-87. doi: 10.1007/s10495-013-0851-5.

PMID:
23700228
18.

Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells.

Teng Y, Gao M, Wang J, Kong Q, Hua H, Luo T, Jiang Y.

Cell Death Dis. 2014 Feb 13;5:e1060. doi: 10.1038/cddis.2014.24.

19.

Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.

Kim IY, Kang YJ, Yoon MJ, Kim EH, Kim SU, Kwon TK, Kim IA, Choi KS.

Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk